Carregando...

Efficacy and safety of lixisenatide as add‐on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal‐O Study

BACKGROUND: This study compared the efficacy and safety of lixisenatide with placebo as add‐on therapy to basal insulin (BI) in adults aged ≥70 years with type 2 diabetes (T2D), with or without moderate renal insufficiency. METHODS: This post hoc analysis evaluated data from non‐frail patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Diabetes
Principais autores: Dailey, George E., Dex, Terry A., Roberts, Michelle, Liu, Minzhi, Meneilly, Graydon S.
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Publishing Asia Pty Ltd 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899823/
https://ncbi.nlm.nih.gov/pubmed/31094074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1753-0407.12952
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!